Clinical trial
A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of…
NCT00420082 · Faes Farma, S.A., Industry · Completed
Key facts
| NCT number | NCT00420082 |
|---|---|
| Title | A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge Chamber |
| Official title | A Randomized, Double-Blind, 4 Way Cross-over, Placebo Controlled Trial to Evaluate the Onset of Action of Bilastine 20 mg vs. Placebo, Cetirizine 10 mg, and Fexofenadine 120 mg in the Vienna Challenge Chamber |
| Lead sponsor | Faes Farma, S.A., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Seasonal Allergic Rhinitis |
| Intervention type | Drug |
| Interventions | Bilastine, Fexofenadine, Cetirizine, Placebo |
| Enrollment | 75 |
| Start date | Oct 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Jan 9, 2007 |
| Last update posted | Apr 5, 2012 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: